161 related articles for article (PubMed ID: 23631130)
21. [Correlation study between OPN, CD44v6, MMP-9 and distant metastasis in laryngeal squamous cell carcinoma].
Yang L; Shang X; Zhao X; Lin Y; Liu J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Nov; 26(21):989-92. PubMed ID: 23373240
[TBL] [Abstract][Full Text] [Related]
22. [Expression and significance of CD44v6 and MMP-9 in laryngeal squamous cell carcinoma].
Qin G; Li W; Sun X; Zhu L; Chen Z
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Aug; 19(15):688-91. PubMed ID: 16248506
[TBL] [Abstract][Full Text] [Related]
23. Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma.
de Vicente JC; Fresno MF; Villalain L; Vega JA; Hernández Vallejo G
Oral Oncol; 2005 Mar; 41(3):283-93. PubMed ID: 15743691
[TBL] [Abstract][Full Text] [Related]
24. [Expression of COX-2 and MMP-9 in cervical carcinoma and their clinical significance].
Luo CF; Zhu RQ; Wang H; Lu YL
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):526-30. PubMed ID: 18069634
[TBL] [Abstract][Full Text] [Related]
25. Expression of type IV collagen, metalloproteinase-2, metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in laryngeal squamous cell carcinomas.
Cao XL; Xu RJ; Zheng YY; Liu J; Teng YS; Li Y; Zhu J
Asian Pac J Cancer Prev; 2011; 12(12):3245-9. PubMed ID: 22471461
[TBL] [Abstract][Full Text] [Related]
26. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
Wei QY; Wu YQ; Fan SQ
Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069
[TBL] [Abstract][Full Text] [Related]
27. [Correlation of EphA2 protein expression with clinicopathological characteristics and prognosis in laryngeal squamous cell carcinoma].
Liu Y; Zhang X; Qiu YZ; Huang DH; Zhou XJ; Tan PQ; Cai GM; Dai YZ; Yu CY; Xiao JY; Tian YQ
Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):197-201. PubMed ID: 21575519
[TBL] [Abstract][Full Text] [Related]
28. [The expression and significance of SDF-1/CXCR4 biological axis in laryngeal squamous cell carcinoma and lymph node metastasize].
Zhang L; Xiong C; Wu Y; Shi H; Jing S; Song J; Zhao Z; Shan B
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Sep; 26(18):798-801. PubMed ID: 23259294
[TBL] [Abstract][Full Text] [Related]
29. [The expression of MMP-2, -9 in the uterine leiomyoma and its significance in prognosis].
Zheng Y; Wang C; Ding J; Jiao S; Si F; Qu L; Bao H
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Nov; 25(22):1037-9. PubMed ID: 22303700
[TBL] [Abstract][Full Text] [Related]
30. Matrix metalloproteinase-2 (MMP-2) and MMP-9 expression in invasive ductal carcinoma of the breast.
Sullu Y; Demirag GG; Yildirim A; Karagoz F; Kandemir B
Pathol Res Pract; 2011 Dec; 207(12):747-53. PubMed ID: 22030137
[TBL] [Abstract][Full Text] [Related]
31. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer].
Fu XR; Zhang C; Chen CY; Zhang L; Wang LX; Wang BH; Liu XY; Zhang MZ
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):369-73. PubMed ID: 22883459
[TBL] [Abstract][Full Text] [Related]
32. [Expression and clinical significance of MMP-2, MMP-9,TIMP-1, and TIMP-2 in breast carcinoma].
Fan SQ; Wei QY; Li MR; Zhang LQ; Liang QC
Ai Zheng; 2003 Sep; 22(9):968-73. PubMed ID: 12969531
[TBL] [Abstract][Full Text] [Related]
33. [The expression and relationship of CXCR4 and microvessel density in laryngeal squamous cell carcinoma].
Zheng C; Ge R; Ge M; Sun X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Feb; 25(3):123-6. PubMed ID: 21553525
[TBL] [Abstract][Full Text] [Related]
34. [Effect of Notch1 on cell cycle, apoptosis and migration of laryngeal squamous cell carninoma cell line Hep-2].
Jiao J; Li S
Zhonghua Zhong Liu Za Zhi; 2012 Feb; 34(2):104-9. PubMed ID: 22780927
[TBL] [Abstract][Full Text] [Related]
35. [Assay of matrix metalloproteinase levels and their endogenous inhibitors in patients with laryngeal carcinoma].
Klisho EV; Savenkova OV; Kondakova IV; Perel'muter VM; Choĭnzonov EL; Shishkin DA
Vopr Onkol; 2007; 53(1):26-31. PubMed ID: 17649730
[TBL] [Abstract][Full Text] [Related]
36. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994
[TBL] [Abstract][Full Text] [Related]
37. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K
Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466
[TBL] [Abstract][Full Text] [Related]
38. [Study on the expression of matrix metalloproteinase-12 and NM_002426 in squamous laryngeal carcinoma].
Liu W; Xiang C; Jia S
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Dec; 20(24):1120-3. PubMed ID: 17357518
[TBL] [Abstract][Full Text] [Related]
39. [Effect of HMGB1 on invasion and migration of human hepatoma cell line HepG2 and its mechanism].
Wang C; Tang C; Chang X; Li Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Nov; 29(11):1159-62. PubMed ID: 24200063
[TBL] [Abstract][Full Text] [Related]
40. [Expressions of COX-2 and MMP-2 in nasopharyngeal carcinoma and the their relationship with lymph node metastasis].
Cui D; Zhang X; Fu Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Aug; 22(15):692-4. PubMed ID: 18950008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
